P. Chanez (Montpellier, France), A. Frew (Southampton, United Kingdom)
Nonallergic rhinitis, sinonasal polyposis and asthma
Z. C. Stojanovski, J. B. Minov (Skopje, Macedonia)
|  |
Asthma among allergic rhinitis patients
S. Baser, S. Ozkurt, B. Topuz, G. Kiter, H. Karabulut, G. Daloglu, M. Kavas, F. Fisekci (Denizli, Turkey)
| |
Prevalence of sensitization to aeroallergens in patients with asthma and/or rhinitis in Thessaloniki Region - Northern Greece
P. Hatzivlassiou, D. Karabekos, P. Christaki, D. Antoniou (Thessaloniki, Greece)
| |
Seasonal allergic rhinitis and respiratory symptoms in general population sample in Republic of Macedonia
S. Risteska-Kuc, V. Cvetanov, N. A. Ezova, S. Milkovska, J. Minov, D. Mijakoski, S. Stoleski (Skopje, Macedonia)
| |
Evaluation of the bronchial inflammation in allergic rhinitic patients following the new ARIA guidelines
C. G. Uasuf, G. E. Carpagnano, A. M. Vignola (Palermo, Bari, Italy)
| |
Prostaglandin E2 levels are elevated in nasal lavages from asthmatic patients with allergic rhinitis
A. Antczak, P. Gorski (Lodz, Poland)
| |
Leukotrienes and metabolites of nitric oxide in exhaled breath condensate of patients with allergic rhinitis in and out of pollen season
P. Cap, J. Chladek, F. Pehal (Prague, Hradec Kralove, Czech Republic)
| |
Leukotriene receptor antagonists for allergic rhino-sinusitis: a systematic review and meta-analysis
A. M. Wilson, K. Parameswaran, P. M. O‘Byrne (Hamilton, Canada)
| |
Allergic rhinitis: three months of follow-up
C. Taieb, E. Myon (Boulogne-Billancourt, France)
| |
Comfortable days and impairment-free days in allergic rhinitis (AR) patients treated with cetirizine and pseudoephedrine combination (CTZ+PSE)
N. Demarteau, C. Arrigo (Belgium)
| |
Comparison of nasal steroids, antileukotrienes and combination therapy in seasonal allergic rhinitis: effect on exhaled breath markers
N. Rovina, C. Gratziou, I. Nikoloutsou, G. Papatheodorou, C. Roussos (Athens, Greece)
| |
Nasal nitric oxide measurements before and after repeated humming manoeuvres
M. Maniscalco, E. Weitzberg, G. De Laurentiis, M. Mormile, L. Carratù, M. Sofia, J. O. Lundberg (Stockholm, Sweden; Naples, Italy)
| |
A comparison of the efficacy of beclomethasone dipropionate (BDP) and fluticasone propionate (FP) aqueous nasal spray on symptoms and quality of life in perennial allergic rhinitis
M. D. Filipovic, S. S. Cekic (Nis, Yugoslavia)
| |
Exhaled NO in upper and lower airways in patients with allergic rhinitis and asthma
Z. S. Arsovski, D. V. Dokic (Skopje, Macedonia)
| |
Diamine oxidase activation by diphenhydramine – in vitro but no in vivo effect
F. Wantke, W. Hemmer, M. Focke, M. Götz, R. Jarisch (Vienne, Austria)
| |
A regression equation for the conversion of plasma IgE to serum IgE in patients with asthma
W. C. Tan, X. Z. Zhang, W. D. Zhang, D. W. Qiu (Singapore, Singapore)
| |
Allergen-specific immunotherapy results in increased IL-10 production of mononuclear cells and T-cell anergy
X. Cheng, C. Wang, B. Zhu, W. Chen, G. Qian (Chongqing, China)
| |
Implications of responsiveness to β2 agonist in patients with asthma
T. Kamimura, T. Koga, Y. Oshita, T. Rikimaru, H. Aizawa (Kurume, Japan)
| |
Does tumor necrosis factor-alpha increase oxidative stress in bronchial asthma?
F. Karadag, A. B. Karul, O. Cildag, C. Altun, M. Eyigor (Aydin, Turkey)
| |
Zafirlukast in asthma; evidence for tolerance and rebound on cessation
D. W. Reid, N. Misso, P. J. Thompson, H. E. Walters (Hobart, Perth, Australia)
| |